CIK 0001894562 · <br>Emerging growth company
Prime Medicine, Inc.
Sign in to watch- Ticker
- PRME
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-465-0013
- Business address
- 60 FIRST ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-24 | NELSEN ROBERT Director | Conversion · Series B Convertible Preferred Stock | −1,141,474 | 0 | ||
| 2022-10-24 | NELSEN ROBERT Director | Conversion · Series A Convertible Preferred Stock | −49,999 | 0 | ||
| 2022-10-24 | Liu David R. 10% owner | Conversion | +321,665 | 21,156,945 | ||
| 2022-10-24 | Liu David R. 10% owner | Conversion · Series A Convertible Preferred Stock | −1,000,001 | 0 | ||
| 2022-10-24 | Cahill Thomas Director | Conversion | +4,905,679 | 4,905,679 | ||
| 2022-10-24 | Cahill Thomas Director | Purchase | +400,000 | $17.00 | $6.8M | 5,305,679 |
| 2022-10-24 | Cahill Thomas Director | Conversion · Series A Convertible Preferred Stock | −9,999,999 | 0 | ||
| 2022-10-24 | Cahill Thomas Director | Conversion · Series B Convertible Preferred Stock | −5,250,781 | 0 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion | +4,124,375 | 4,124,375 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion | +98,967 | 98,967 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion | +11,015 | 109,982 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion | +3,805,080 | 3,805,080 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion | +423,509 | 4,228,589 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion · Series A Convertible Preferred Stock | −4,124,375 | 0 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion · Series A Convertible Preferred Stock | −98,967 | 0 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion · Series B Convertible Preferred Stock | −11,015 | 0 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion · Series A Convertible Preferred Stock | −3,805,080 | 0 | ||
| 2022-10-24 | FMR LLC See Remark 1 | Conversion · Series B Convertible Preferred Stock | −423,509 | 0 | ||
| 2022-10-19 | Chung Wendy Director | Grant or award · Stock Option (right to buy) | +9,006 | 9,006 | ||
| 2022-10-19 | Foster-Cheek Kaye I Director | Grant or award · Stock Option (right to buy) | +9,006 | 9,006 |
Page 12 of 13 · 241 trades